Skip to main content
. 2023 Jun 9;12(6):1221–1235. doi: 10.21037/tlcr-22-815

Table 3. NHLRC2 expression in cancer cells of lung adenocarcinoma and squamous cell carcinoma.

Cancer type Negative, n (%) <25% positive, n (%) 25–49% positive, n (%) 50–75% positive, n (%) >75% positive, n (%) Total, n (%) P value
Adenocarcinoma 2 (2.0) 6 (5.9) 18 (17.6) 26 (25.5) 50 (49.0) 102 (100.0) <0.001
Squamous cell carcinoma 1 (0.9) 42 (37.8) 28 (25.2) 22 (19.8) 18 (16.2) 111 (100.0)
Total 3 (1.4) 48 (22.5) 46 (21.6) 48 (22.5) 68 (31.9) 213 (100.0)

NHLRC2, NHL repeat (named after NCL-1, HT2A and LIN-41)-containing protein 2.

HHS Vulnerability Disclosure